4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid(CAS: 2197414-57-4)

Regulatory guidelines for 4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid (CAS: 2197414-57-4) include GHS classification for physical and health hazards, REACH regulations for European manufacturers, and FDA/EPA requirements for pharmaceutical and environmental safety. Ensuring compliance with these guidelines is crucial for product safety and legal market entry.

Alternatives to 4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid (CAS: 2197414-57-4) in synthesis include similar amino acids and derivatives with similar functional groups. Common substitutes include other amino acids like L-lysine or L-arginine, and isomers with different physical properties. These can serve as effective reagents in various chemical processes.

The market for 4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid (CAS: 2197414-57-4) is growing due to its application in pharmaceuticals and research. Recent trends suggest increasing research into its potential as a therapeutic agent and its use in developing new drug compounds. Prices and demand are expected to fluctuate based on these developments.

Waste containing 4-(4-Amino-1-oxoisoindolin-2-yl)-4-carbamoyl Butyric Acid (CAS: 2197414-57-4) should be collected in secure containers and disposed of through professional waste disposal services. Incineration or chemical treatment may be necessary to ensure complete decomposition. Environmental protection measures, such as preventing runoff into water bodies, should be adhered to during disposal to minimize ecological impact.